New Class of Antibiotics Targeting Bacterial Membranes

Ross highlights Liverpool research on Nolvotex that disrupts bacterial lipid membranes, showing potent in vitro activity against resistant pathogens.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!